Enanta Pharmaceuticals Inc (ENTA)

[dewophile]

I've never paid attention to job openings for pharma so no informed opinion here
On the one hand lack of hiring (and indeed cutting costs per some posts) suggests no imminent cash coming in via partnership, but it could suggest interest via a buyout
enta is not exactly cash starved so at a minimum it suggests management realizes that the value if the clinical programs don't pan out is in the cash and remaining royalty, which even accounting for 2-3 quarters of burn is well above present prices